Clinical and pharmacological phase I evaluation of ExherinTM (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours (Q62944928)
scientific article published on 03 February 2009
Language:
(P31) (Q13442814)
(P50) (Q42882458)
(Q58350775)
(Q56629673)
(P304) 741-745
(P407) (Q1860)
(P433) 4
(P478) 20
(P577) Tuesday, February 3, 2009
(P921) (Q103824)
(Q128406)
(P1433) (Q326122)
(P1476) "Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours" (language: en)
(P2093) A Perotti
C Sessa
A Mancuso
C Noberasco
A Locatelli
M L Carcangiu
K Passera
A Braghetti
D Scaramuzza
F Zanaboni
A Fasolo
M Miani
W P Peters
other details
description scientific article published on 03 February 2009

External Links